RINOSEDIN gtt nas 0.1 % 10 ml

7680533490214 CH-53349 R01AA07 12.02.1.
RINOSEDIN gtt nas 0.1 % 10 ml
RINOSEDIN gtt nas 0.1 % 10 ml
RINOSEDIN gtt nas 0.1 % 10 ml
1 / 3
google

Details

Product number
5334902
CPT
-
Packaging group
10
Unit
ml
Composition
xylometazolini hydrochloridum 1.000 mg, benzalkonii chloridum 0.125 mg, dinatrii phosphas, natrii dihydrogenophosphas dihydricus, aqua purificata, excipiens ad solutionem pro 1 ml, xylometazolini hydrochloridum 0.03 mg pro gutta, pro vase 333 guttae.

Articles (1)

Rinosedin 0,1 %, Nasentropfen, Lösung
Nasentropfen
10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
21/03/2025
Patient information leaflet
Français
21/03/2025
Patient information leaflet
Italien
21/03/2025
Professional SmPC
Allemand
07/03/2025
Professional SmPC
Français
07/03/2025
Professional SmPC
Italien
07/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MG Substance WIZUS
(N/A)
0.125 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.03 MG Substance Wirkstoff (Principe actif)

Reimbursement information

Public price
CHF 3.65
Specialties list
Yes
Generic
No
SL addition date: 15/03/1997

Authorization holder

Streuli Pharma AG

8730 Uznach

Authorization information

Swissmedic authorization number
53349
Drug name
Rinosedin, Nasentropfen, Lösung
Galenic form
NASNL
ATC Code
R01AA07
Authorization status
Z
Dispensation category
D
First authorization
04/07/1996
Authorization expiration date
31/12/9999
IT number
12.02.1.
Domain
Human medicine
Field of application
Schnupfen

Packaging details

Description (FR)
RINOSEDIN gtt nas 0.1 % 10 ml
Description (DE)
RINOSEDIN Gtt Nas 0.1 % 10 ml
Market launch
04/07/1996
Narcotic (BTM)
No

Other packaging sizes

RINOSEDIN gtt nas 0.05 % 10 ml
10 ML
View